PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-147.93%
Both yoy net incomes decline, with CRON.TO at -242.31%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
34.91%
D&A growth well above CRON.TO's 47.76%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-361.92%
Negative yoy deferred tax while CRON.TO stands at 175.88%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
54.05%
SBC growth well above CRON.TO's 4.52%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-131.10%
Negative yoy working capital usage while CRON.TO is 2.54%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-1658.73%
Both yoy AR lines negative, with CRON.TO at -105.92%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-130.60%
Both reduce yoy inventory, with CRON.TO at -12.18%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
1927.11%
A yoy AP increase while CRON.TO is negative at -490.90%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-323.05%
Negative yoy usage while CRON.TO is 181.22%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
72.93%
Lower 'other non-cash' growth vs. CRON.TO's 171.23%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-32.18%
Negative yoy CFO while CRON.TO is 1.55%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
31.18%
Some CapEx rise while CRON.TO is negative at -14.18%. John Neff would see competitor possibly building capacity while we hold back expansions.
99.43%
Some acquisitions while CRON.TO is negative at -49.23%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
461.81%
We have some liquidation growth while CRON.TO is negative at -101.53%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
441472.65%
Growth well above CRON.TO's 41.72%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
106.25%
We have mild expansions while CRON.TO is negative at -132.64%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
73.30%
We repay more while CRON.TO is negative at -64.29%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.